AnGes, Inc.

n/a

BLIRT S.A.

BLIRT, Biolab Innovative Research Technologies, is a European Biotech Company that started as a Technical University spin off over 25 years ago to become a well established recombinant enzyme manufacturer in the Life Science Industry. BLIRT manufactures reagents used in nucleic acid based diagnostic tests, such as RT qPCR, RT LAMP, and in situ sequencing, a relatively novel methods used in cancer detection.

JPRO/WDA Western univ.

***

LTS Lohmann Therapie-Systeme AG

Lohmann Therapie-Systeme (LTS) 是一家全球领先的透皮给药贴剂（TTS）和口溶膜/口颊膜 (OTF)研发和生产企业。我们在德国和美国拥有最先进的研发和生产线，代表我们的众多客户向全球制药市场（包括中国）供货。由LTS研发的产品涵盖非常广泛的治疗领域，例如创新药产品艾斯能透皮贴（利斯的明，阿兹海默症）和优普洛透皮贴（罗替高汀，帕金森症）。MAP技术（微针贴片）是一种LTS近期正在提供的一种新兴的给药技术，适用于生物制品、大分子和疫苗。我们已经完成建立了生产GMP样品的中试生产线，并已获得德国药监局批准，可以为您供临床样品，直至临床II期样品。我们期待向您介绍LTS的药物传输技术和服务，并期待与您的合作研究机会。

Micro Solutions Tomasz Guz Sp. j.

致⼒于提供图像分析，实验室⾃动化，实验室信息管理系统发展，⽹络/云端的定制软件解决⽅案
的医疗IT公司。
建⽴在2008年。
总部在弗罗茨⽡夫⼀波兰的硅⾕。
拥有ISO 13485认证证书。
基础和⾼级编程的知识。
3S软件-稳定（stable），可扩展（scalable），及智能（smart）。

Minitab 台灣總代理昊青股份有限公司

Minitab 透過提供首屈一指的全面資料分析和流程改進工具，幫助各公司和機構聚焦趨勢、解決問題並發掘具有價值的數據見解。結合無與倫比的易用性，Minitab 讓從資料中獲得深入見解變得前所未有的簡單。此外，經過專業培訓的資料分析專家組成的團隊，確保使用者能夠從分析中獲得最大收益，作出更好、更快、更準確的決策！近五十年來 Minitab 以其專有的解決方案，幫助企業實現成本控制、提升品質、增加客戶滿意度並且提高效率。
- 品質改善
- 流程改善
- 預測分析
- Real Time SPC
- 專業技術支援
- 原廠認證課程
Minitab台灣總代理昊青公司 SFI (Scientific Formosa, Inc) 為專業軟硬體代理商，從事各式網路通訊、數值財經及工程應用軟體之銷售及服務。 本著服務客戶的熱忱，我們亦不斷地提昇，隨時瞭解客戶的需求，提供最佳的解決方案。

MSD

Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From Merck’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. In 2020 Merck had sales of more than $48 billion and we operate in more than 140 countries.

Sanofi

Sanofi is a global pharmaceutical company and extensively pursues innovation to seek collaborations to build alliances that create value for global health.
At our team, we’re eagerly searching external opportunities, whether pipelines or technology platforms, in Asian regions towards global collaborations.
Our scope of business covers a wide variety of therapeutic indications as follows.
・Oncology
・Immunology
・Rare Diseases
・Neurology
・Rare Blood Diseases
・Vaccine
・Tech Platforms

SCOHIA PHARNA, Inc.

NA

ソシウム株式会社

SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months. By taking a systems biology approach using our Augmented intelligence and Machine Learning – instead of hypothesizing the mechanism of a disease and focusing on only a few related compounds, we profile the entire disease by analyzing various OMICS data.